María José Remigia

Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients

Concepción Gimeno, Carlos Solano, José C. Latorre et al. · Journal of Clinical Microbiology · 2008 · 114 citations · Full text

Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study

Manuel Jurado, Claudia De La Mata, A. Ruiz‐García et al. · Cytotherapy · 2017 · 93 citations

Regenerative Medicine, Tissue Engineering, Cell Therapy +12

Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation

Noemí Puig, Javier de la Rubia, María José Remigia et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 69 citations

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8+ and CD4+ T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Nuria Tormo, Carlos Solano, Isabel Benet et al. · Bone Marrow Transplantation · 2011 · 63 citations

Transplantation, Cmv Dnaemia, Medicine +12

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Nuria Tormo, Carlos Solano, Isabel Benet et al. · Bone Marrow Transplantation · 2009 · 56 citations

Cell Therapy, Transplantation, Immunodeficiencies +12